glp-1 antagonist drugs The Agonists and Obesity: How Diabetes are Changing Non-Diabetic Lives — tl;dr pharmacy GLP-1 Drug Comparison in Diabetes
Description
The primary goal of this article is to emphasize the extensive benefits of using GLP-1RAs in treating a broad spectrum of diseases, such as obesity, cardiovascular diseases, non-alcoholic fatty liver disease (NAFLD), neurodegenerative diseases, musculoskeletal inflammation, and various forms of cancer
Always follow your providers guidance and reach out with any questions or concerns
Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis
It should be noted that while GLP-1 agonists positively impact metabolism upstream of the liver, this may not subsequently improve the fibrotic liver injury within the tested treatment duration
Manifestations can vary from isolated liver enzyme elevation to fulminant hepatic failure
